Tinnitus and Arterial Hypertension
Study Details
Study Description
Brief Summary
Many authors link tinnitus to arterial hypertension. The aim of this study is to establish a possible relationship between them, analyze the severity of tinnitus related to arterial hypertension and analyze a possible influence of ototoxic drugs used to treat arterial hypertension
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Arterial hypertension has been cited as a possible tinnitus etiology. Vascular abnormalities associated with it may account for cochlear and central nervous system. However, a relationship between tinnitus and arterial hypertension has never been established. The aim of this study is to analyze this relationship, comparing groups with and without arterial hypertension and the incidence of tinnitus amongst them. Inclusion and exclusion criteria try to isolate arterial hypertension as the main etiological factor, as much as possible. Presbycusis, noise exposure, metabolical diseases and genetic factors will be ruled out. A comparison will be performed inside the arterial hypertension group between subgroups that use or not ototoxic medications, such as furosemide and beta-blockers
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Control Normal subjects |
|
AH Arterial hypertension patients |
Outcome Measures
Primary Outcome Measures
- Incidence of tinnitus - have tinnitus x don't have tinnitus [Up to 6 months]
The purpose of this study is to compare tinnitus incidence between patients with and without arterial hypertension.
Secondary Outcome Measures
- Severity of tinnitus - Tinnitus Handicap Inventory [Up to 6 months]
Severity of tinnitus measured by Tinnitus Handicap Inventory, to evaluate differences between patients with and without arterial hypertension
Eligibility Criteria
Criteria
Inclusion Criteria:
-
age between 40 and 50
-
arterial hypertension for group 1
-
at least 5 years standing arterial hypertension
Exclusion Criteria:
-
chronic noise exposure
-
metabolic diseases
-
family antecedents of hearing loss (except for presbycusis)
-
pregnant women
-
use of ototoxic drugs (except for anti-hypertensives)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Faculdade de Medicina de Valença | Valença | RJ | Brazil | 27660-000 |
Sponsors and Collaborators
- Faculdade de Medicina de Valenca
- Federal University of São Paulo
Investigators
- Principal Investigator: Ricardo R Figueiredo, MD,MSc, Otosul, Valença Medical School
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HAS